p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c‐Kit activity
暂无分享,去创建一个
A. Elia | P. Provero | A. Sapino | I. Castellano | E. Turco | P. Bernabei | M. Spadaro | P. Defilippi | S. Cabodi | Alessandra Pincini | G. Tornillo | B. Bisarò | M. P. Camacho-Leal
[1] L. Trusolino,et al. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer , 2013, Oncogene.
[2] Francesca Orso,et al. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells , 2012, Breast Cancer Research.
[3] C. Caldas,et al. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland , 2012, Breast Cancer Research.
[4] L. Rönnstrand,et al. Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.
[5] Yibin Kang,et al. Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling , 2012, Stem cells.
[6] H. Park,et al. FoxM1 regulates mammary luminal cell fate. , 2012, Cell reports.
[7] Wenjun Guo,et al. Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.
[8] B. Groner,et al. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer , 2012, Oncogene.
[9] C. Perou,et al. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium , 2011, Proceedings of the National Academy of Sciences.
[10] M. Glukhova,et al. The mammary myoepithelial cell. , 2011, The International journal of developmental biology.
[11] E. Golemis,et al. NEDD9 and BCAR1 Negatively Regulate E-Cadherin Membrane Localization, and Promote E-Cadherin Degradation , 2011, PloS one.
[12] J. Visvader,et al. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit , 2011, Oncogene.
[13] P. Provero,et al. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. , 2011, European journal of cell biology.
[14] E. Lander,et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.
[15] V. Cryns,et al. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. , 2011, Molecular endocrinology.
[16] M. Pegram,et al. Triple negative breast cancer: unmet medical needs , 2011, Breast Cancer Research and Treatment.
[17] Jane E. Visvader,et al. Cells of origin in cancer , 2011, Nature.
[18] P. Defilippi,et al. Integrin signalling adaptors: not only figurants in the cancer story , 2010, Nature Reviews Cancer.
[19] David R. Croucher,et al. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. , 2010, Cancer research.
[20] G. Forni,et al. p130Cas is an essential transducer element in ErbB2 transformation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] A. Ashworth,et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.
[22] C. Brisken,et al. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates , 2010, Cell Death and Differentiation.
[23] E. Golemis,et al. CAS proteins in normal and pathological cell growth control , 2010, Cellular and Molecular Life Sciences.
[24] J. Visvader,et al. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. , 2009, Genes & development.
[25] S. Fox,et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.
[26] S. Sinha,et al. An Active Role of the ΔN Isoform of p63 in Regulating Basal Keratin Genes K5 and K14 and Directing Epidermal Cell Fate , 2009, PloS one.
[27] J. Stingl. Detection and analysis of mammary gland stem cells , 2009, The Journal of pathology.
[28] M. Zvelebil,et al. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate , 2008, BMC Genomics.
[29] J. Visvader,et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. , 2008, Cell stem cell.
[30] Z. Werb,et al. GATA-3 and the regulation of the mammary luminal cell fate. , 2008, Current opinion in cell biology.
[31] A. Welm,et al. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. , 2008, Cell stem cell.
[32] M. Smalley,et al. Prospective Isolation and Functional Analysis of Stem and Differentiated Cells from the Mouse Mammary Gland , 2007, Stem Cell Reviews.
[33] M. Cole,et al. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. , 2007, Cancer research.
[34] A. Ashworth,et al. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland , 2007, The Journal of cell biology.
[35] C. Eaves,et al. Deciphering the Mammary Epithelial Cell Hierarchy , 2006, Cell cycle.
[36] A. Sapino,et al. Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure , 2006, Virchows Archiv.
[37] A. Sapino,et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. , 2006, Cancer research.
[38] Paola Defilippi,et al. p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.
[39] Haiyan I. Li,et al. Purification and unique properties of mammary epithelial stem cells , 2006, Nature.
[40] A. Ashworth,et al. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells , 2005, Breast Cancer Research.
[41] R. Roskoski. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. , 2005, Biochemical and biophysical research communications.
[42] A. Ashworth,et al. Hallmarks of 'BRCAness' in sporadic cancers , 2004, Nature Reviews Cancer.
[43] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[44] K. Wilson,et al. Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase* , 2004, Journal of Biological Chemistry.
[45] C. Watson,et al. A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland , 2000, Breast Cancer Research.
[46] M. O'hare,et al. Differentiation of Separated Mouse Mammary Luminal Epithelial and Myoepithelial Cells Cultured on EHS Matrix Analyzed by Indirect Immunofluorescence of Cytoskeletal Antigens , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[47] J. Groopman,et al. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis. , 1998, Journal of immunology.
[48] J. Visvader,et al. Delineating the epithelial hierarchy in the mouse mammary gland. , 2008, Cold Spring Harbor symposia on quantitative biology.
[49] G. Sauter,et al. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] M. Loda,et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. , 2002, Cancer research.